Medtronic received information via literature review that a study was performed to evaluate whether the implantation technique of the freestyle stentless bioprosthesis (fsb) (serial numbers not provided) had an impact on late reoperation for structural valve deterioration (svd).The study population included 531 patients predominantly male with a mean age of 68 years.Among all patients, 281 deaths occurred over a 20 year period, which included: chronic obstructive pulmonary disease, reoperation for all causes, and older age.Of these deaths, none were directly attributed to the valve or its function.Among all patients, all reported adverse events included: atrial fibrillation (afib), bleeding, renal failure, stroke, mediastinitis, patient-prosthesis mismatch, endocarditis, leaflet tear, calcification, aortic insufficiency, paravalvular leak (pvl), reoperation for structural valve deterioration (svd) and non-svd causes (median time 4.2-12 years depending on implant technique).No additional adverse patient effects were reported.
|